Hutch News

Hutch News

Stories tagged 'Cecilia Yeung'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >


Pathologist Yeung joins Clinical Research Division

Cecilia Yeung’s research focuses on the molecular signatures of lymphomas, leukemias to guide diagnosis, treatment

Aug. 29, 2011 | By Colleen Steelquist

Dr. Cecilia Yeung, who wears dual hats as a hematopathologist and a molecular genetics pathologist, joined the faculty of the Pathology Labs in the Fred Hutchinson Cancer Research Center's Clinical Research Division this month.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.